Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3

Sponsor Class

INDUSTRY 38OTHER 10NIH 4NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Anemia 3Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Fatigue 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1

Interventions

Epoetin Alfa 3Cisplatin 2Radiotherapy 1Erythropoietin 1Dexamethasone 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Anemia × Epoetin Alfa × Clear all
NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
282 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

NCT00004917 2020-10-22

Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anemia, Head and Neck Neoplasms

NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

GOG Foundation

Phase 3 Completed
114 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡